Johnson & Johnson Coronavirus vaccine illustration Dado Ruvic | Reuters Dr. Rochelle Walensky, director of the Centers for Disease Control and Prevention, signed off Sunday on Johnson & Johnson‘s one-shot Covid-19 vaccine for those 18 years of age and older as the federal government prepares to ship out millions of doses this week. Walensky’s green… Read More »
The Food and Drug Administration has approved Johnson & Johnson‘s Covid-19 vaccine for emergency use, giving the United States a third tool to fight the pandemic as highly contagious variants start to take root across the country. The FDA’s emergency use authorization Saturday kickstarts the federal government’s plan to distribute nearly 4 million doses of… Read More »
Johnson & Johnson board member Dr. Mark McClellan says the company expects 20 million doses delivered by the end of March as the U.S. becomes one step away from adding a third safe and effective vaccine to its arsenal. “There is going to be a ramp-up period, so 4 million doses expected next week, going… Read More »
A month after Johnson & Johnson’s COVID-19 vaccine posted positive data in a phase 3 study, the shot is almost ready for prime time. Late Friday, a key panel unanimously endorsed the vaccine for emergency use and sent it to the agency for an official decision. An FDA authorization for the one-dose vaccine would provide a quick lift… Read More »
[unable to retrieve full-text content]Symptoms left unchecked included lumps, changes to moles and coughing up blood, a survey finds. BBC News – Health